FMAO vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 18, 2026

FMAO

57.5
AI Score
VS
FMAO Wins

CARE

52.2
AI Score

Investment Advisor Scores

FMAO

58score
Recommendation
HOLD

CARE

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FMAO CARE Winner
Forward P/E 15.9236 13.6612 CARE
PEG Ratio 0 0 Tie
Revenue Growth 16.5% 260.0% CARE
Earnings Growth 37.3% 900.8% CARE
Tradestie Score 57.5/100 52.2/100 FMAO
Profit Margin 29.0% 41.8% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

FMAO 1M: +9.5% · 3M: +23.3% CARE 1M: +6.9% · 3M: +36.9%

Current Technical Phase

FMAO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.0% over 20 days), RSI 64

RSI (14): 64.3 · Price: $33.59

CARE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.5% over 20 days), RSI 70

RSI (14): 70.0 · Price: $35.43

Fundamentals Snapshot

Metric FMAO CARE
Market Cap
Forward P/E 10.3 13.8
Trailing P/E 12.7 6.0
Revenue (TTM)
Revenue Growth 0.2% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.5% 0.6%
EPS 2.62 5.80
Dividend Yield 0.03% 0.00%

Frequently Asked Questions

Based on our detailed analysis, FMAO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.